Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

2.5K
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
2.5K
Antibody Structure01:10

Antibody Structure

58.8K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
58.8K
Antibody Structure and Classes01:25

Antibody Structure and Classes

737
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
737
Antibody Actions01:26

Antibody Actions

1.0K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.0K
Diversity of Antigen Receptors01:28

Diversity of Antigen Receptors

490
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
490
Affinity and Avidity01:41

Affinity and Avidity

35.8K
Overview
35.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Muscle macrophage regenerative response after squalene-adjuvanted influenza vaccination is associated with type II-skewed response and is reduced with age.

NPJ vaccines·2026
Same author

Myeloid-avid mammalian target of rapamycin-inhibiting nanobiologic attenuates allograft fibrosis after lung transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

Assistive technology devices for enhancing sleep quality: a scoping review.

Disability and rehabilitation. Assistive technology·2026
Same author

Genotypic challenges in implementing broadly neutralizing antibody-based long-acting HIV-1 therapies.

Communications medicine·2026
Same author

A multiplexed, systems-based approach for prediction of antibody neutralization breadth for soluble human receptors.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same author

Breast milk antibody Fc signatures track with HIV transmission during breastfeeding in ART-naïve mothers.

iScience·2026
Same journal

Discovery and optimization of a pH-responsive ultra-long-acting VHH-based growth hormone mimetic.

mAbs·2026
Same journal

Efficient inference of non-polyreactive antibody variants dependent on local fine-tuning.

mAbs·2026
Same journal

Impact of ASO conjugation and receptor binding affinity on intracellular transport of mono- and bispecific TfR- and CD98-Brainshuttle<sup>TM</sup> variants.

mAbs·2026
Same journal

Development of single-chain C1q affinity chromatography-mass spectrometry for the glycoform-resolved characterization of low-affinity immunoglobulin G interactions.

mAbs·2026
Same journal

Biparatopic targeting of IL-23 enables dual-epitope engagement and enhanced neutralization potency.

mAbs·2026
Same journal

Comparison of knockdown approaches for the generation of stable cell populations expressing afucosylated antibodies.

mAbs·2026
See all related articles

Related Experiment Video

Updated: May 28, 2025

Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF
09:39

Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF

Published on: September 17, 2019

6.8K

Combinatorial Fc modifications for complementary antibody functionality.

Yannic C Bartsch1,2, Nicholas E Webb1, Eleanor Burgess1

  • 1Ragon Institute of Mass General, MIT, and Harvard, Cambridge, Massachusetts, USA.

Mabs
|February 14, 2025
PubMed
Summary
This summary is machine-generated.

Combining engineered Fc variants of therapeutic monoclonal antibodies (mAbs) can enhance function. Strategic selection of complementary Fc modifications, especially with distinct antibody specificities, broadens functional activity.

Keywords:
Broadly functional antibodiesFc-modificationscomplimentary combinations

More Related Videos

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity
11:13

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Published on: July 12, 2018

8.6K
Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo
10:35

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo

Published on: February 5, 2021

3.3K

Related Experiment Videos

Last Updated: May 28, 2025

Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF
09:39

Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF

Published on: September 17, 2019

6.8K
A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity
11:13

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Published on: July 12, 2018

8.6K
Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo
10:35

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo

Published on: February 5, 2021

3.3K

Area of Science:

  • Immunology and biotechnology
  • Protein engineering and antibody therapeutics

Background:

  • Therapeutic monoclonal antibodies (mAbs) are crucial biologics.
  • Fc engineering offers a method to enhance mAb effector functions.
  • Combining engineered mAbs could lead to synergistic therapeutic benefits.

Purpose of the Study:

  • To investigate the functional complementarity of paired mAbs with different Fc modifications.
  • To assess the impact of Fc engineering on mAb activity in HIV-1 antibody libraries.
  • To determine if combining Fc variants can enhance functional breadth and activity.

Main Methods:

  • Utilized two HIV-1 monoclonal antibody (mAb) libraries.
  • Each library contained 60 distinct engineered Fc variants.
  • Evaluated in vitro activity of mAb pairs with various Fc modifications.

Main Results:

  • Fc engineering impact is dependent on the specific antibody (Fab) clone.
  • Combinations of Fc variants from distinct Fabs showed greater functional enhancement than those with the same Fab specificity.
  • Some Fc variant combinations yielded additive effects, while others were detrimental, indicating unpredictable outcomes.

Conclusions:

  • Complementary Fc modifications in mAb combinations show potential for enhanced functional activity and breadth.
  • Strategic pairing of Fc variants, particularly with different specificities, is key.
  • Further research is needed to optimize Fc modifications for in vivo efficacy.